These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28515105)

  • 21. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
    J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
    Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
    Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
    Sailer V; Gevensleben H; Dietrich J; Goltz D; Kristiansen G; Bootz F; Dietrich D
    PLoS One; 2017; 12(6):e0179412. PubMed ID: 28617833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
    Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
    Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum biomarkers for detection of head and neck squamous cell carcinoma.
    Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
    Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
    Egyud M; Sridhar P; Devaiah A; Yamada E; Saunders S; Ståhlberg A; Filges S; Krzyzanowski PM; Kalatskaya I; Jiao W; Stein LD; Jalisi S; Godfrey TE
    Head Neck; 2019 May; 41(5):1351-1358. PubMed ID: 30554450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Dynamics of Quantitative
    Krausewitz P; Kluemper N; Richter AP; Büttner T; Kristiansen G; Ritter M; Ellinger J
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
    Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
    Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
    Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
    PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer.
    Hayashi M; Guerrero-Preston R; Okamura J; Michailidi C; Kahn Z; Li X; Ahn J; Goldsmith M; Koch W
    Ann Surg Oncol; 2014 Sep; 21(9):3124-31. PubMed ID: 24671639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
    Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
    Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
    Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
    Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
    Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood.
    Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA; Shin DM; Saba NF; Smith AK; Burtness B; Park HS; Stokes WA; Beitler JJ; Xiao C
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1217-1228. PubMed ID: 36410685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
    Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
    Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.